CF
AGN

Cypress Funds’s Allergan plc AGN Stock Holding History

Cypress Funds’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-91,000
Closed -$24.7M – 30
2015
Q3 		$24.7M Sell
91,000
-9,000
-9% -$2.76M 7.17% 3
2015
Q2 		$30.3M Sell
100,000
-200
-0.2% -$59.7K 9.17% 1
2015
Q1 		$29.8M Hold
100,200
– – 7.84% 3
2014
Q4 		$25.8M Buy
100,200
+18,200
+22% +$4.55M 6.8% 8
2014
Q3 		$19.8M Buy
+82,000
New +$18.4M 6.23% 6

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Cypress Funds's AGN Position: Q4 2015 in Review

Cypress Funds sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 91,000 shares — an estimated $24.7M sold.

Cypress Funds first reported a position in AGN in Q3 2014 and held it in 5 quarters. The position peaked at $30.3M in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Cypress Funds reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Cypress Funds sold 91,000 Allergan plc shares in Q4 2015, an estimated $24.7M.
  • Cypress Funds first reported a position in Allergan plc in Q3 2014 and held it in 5 quarters.
  • Cypress Funds's Allergan plc position peaked at $30.3M in Q2 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Cypress Funds's 13F filing for Q4 2015, filed 10 Feb 2016.